Kirtane, Ameya R. http://orcid.org/0000-0002-3779-0363
Verma, Malvika http://orcid.org/0000-0001-7043-5120
Karandikar, Paramesh http://orcid.org/0000-0002-3529-2037
Furin, Jennifer
Langer, Robert http://orcid.org/0000-0003-4255-0492
Traverso, Giovanni http://orcid.org/0000-0001-7851-4077
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (EB000244)
Article History
Received: 14 June 2019
Accepted: 26 January 2021
First Online: 22 March 2021
Competing interests
: A.R.K., M.V., R.L. and G.T. are co-inventors on multiple patent applications describing gastric resident systems for extended drug release with a focus on global health applications. R.L. has a financial interest in Moderna, Inc, and Alnylam, Inc., which are biotechnology companies focused on RNA therapeutics including vaccines against SARS-CoV-2. R.L. and G.T. have a financial interest in Lyndra Therapeutics, Inc., a biotechnology company focused on the development of encapsulated gastric resident systems for extended drug delivery.
Free to read: This content has been made available to all.